Partnering: VasoDynamics Signs a Long-term Partnership Agreement with Cambrex for the Supply of Active Pharmaceutical Ingredients. Gallery Partnering: VasoDynamics Signs a Long-term Partnership Agreement with Cambrex for the Supply of Active Pharmaceutical Ingredients. By Ibrahim|2025-12-05T12:23:34+00:00December 3rd, 2025|News, Fundraising| Read More
Regulatory: VasoDynamics is accepted for Parallel Scientific Advice Meeting with EMA-FDA Gallery Regulatory: VasoDynamics is accepted for Parallel Scientific Advice Meeting with EMA-FDA By Ibrahim|2025-11-28T15:22:19+00:00November 21st, 2025|News, Fundraising| Read More
NG13-2 Clinical Study: MHRA Scientific Advisory Meeting on Clinical Study Design and Approval Path Gallery NG13-2 Clinical Study: MHRA Scientific Advisory Meeting on Clinical Study Design and Approval Path By Ibrahim|2025-11-28T15:21:38+00:00September 18th, 2025|News, NG13| Read More
Setting Footprint in Europe: VasoDynamics setting up VDL Pharma B.V. in Leiden Bioscience Park, the Netherlands Gallery Setting Footprint in Europe: VasoDynamics setting up VDL Pharma B.V. in Leiden Bioscience Park, the Netherlands By Ibrahim|2025-11-28T15:20:44+00:00August 18th, 2025|Corporate Development, News| Read More
UK MHRA Scientific Advice on Pivotal Trial of NG13-2, a Novel Product for the Prevention of Chemotherapy-Induced Alopecia Gallery UK MHRA Scientific Advice on Pivotal Trial of NG13-2, a Novel Product for the Prevention of Chemotherapy-Induced Alopecia By Jack Whitby|2025-11-28T15:23:08+00:00July 11th, 2025|News, NG13| Read More
UK MHRA Scientific Advice on Pivotal Trial of NG11-2, a Novel Product for the Prevention of Oral Mucositis Gallery UK MHRA Scientific Advice on Pivotal Trial of NG11-2, a Novel Product for the Prevention of Oral Mucositis By Jack Whitby|2025-08-07T08:28:09+00:00June 20th, 2025|News, NG11| Read More
VasoDynamics receives PING Innovation Award 2025 Gallery VasoDynamics receives PING Innovation Award 2025 By Jack Whitby|2025-08-05T14:52:36+00:00May 23rd, 2025|News| Read More
NG11-2 Phase Ib clinical study in oral mucositis: UK MHRA confirms Scientific Advisory review meeting for June with feedback in late July 2025 Gallery NG11-2 Phase Ib clinical study in oral mucositis: UK MHRA confirms Scientific Advisory review meeting for June with feedback in late July 2025 By Chloe Atkinson|2025-08-05T10:23:46+00:00April 28th, 2025|News| Read More
NG11-2 Phase-Ib Clinical Study Results Summary Available Gallery NG11-2 Phase-Ib Clinical Study Results Summary Available By Chloe Atkinson|2025-06-09T09:17:16+00:00March 5th, 2025|News| Read More
NG11-2 Phase-Ib Clinical Study Report Complete Gallery NG11-2 Phase-Ib Clinical Study Report Complete By Chloe Atkinson|2025-05-20T09:41:22+00:00January 20th, 2025|News| Read More
